Literature DB >> 11558630

Mouse models of metastatic pancreatic adenocarcinoma.

K Xie1, B Wang, Q Shi, J L Abbruzzese, Q Xiong, X Le.   

Abstract

Pancreatic adenocarcinoma is a deadly disease. Its etiology is unknown, and metastatic disease kills the majority of patients who have it. Effective prevention is clearly the ultimate goal for eradicating this disease provided that the effects of environmental and genetic elements on pancreatic cancer development are fully understood. Currently, it appears that the control of pancreatic cancer metastasis is of immediate urgency. Fulfillment of this difficult task relies on knowledge of the cellular and molecular biology of metastasis. The use of relevant animal models will help define each aspect of this complicated process.

Entities:  

Mesh：

Year:  2001        PMID： 11558630     DOI： 10.1385/IJGC:29:1:25

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN： 0169-4197


  79 in total

1.  Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.

Authors:  I J Fidler; C Bucana
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

2.  Human gastric choriocarcinoma serially transplanted in nude mice.

Authors:  T Kameya; Y Shimosato; M Tumuraya; N Ohsawa; T Nomura
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

3.  Tumor angiogenesis and tissue factor.

Authors:  J Folkman
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

4.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

Review 5.  Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.

Authors:  K Xie; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters.

Authors:  S Okita; M Tsutsumi; M Onji; Y Konishi
Journal:  Mol Carcinog       Date:  1995-08       Impact factor: 4.784

7.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

8.  Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

Authors:  T H Corbett; B J Roberts; W R Leopold; J C Peckham; L J Wilkoff; D P Griswold; F M Schabel
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

Review 9.  Carcinogenesis in the pancreas.

Authors:  D S Longnecker
Journal:  Arch Pathol Lab Med       Date:  1983-02       Impact factor: 5.534

10.  Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Authors:  J Itakura; T Ishiwata; H Friess; H Fujii; Y Matsumoto; M W Büchler; M Korc
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531
View more
  2 in total

Review 1.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer.

Authors:  Laxmidhar Das; Manjula Vinayak
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.